XML 56 R38.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 28, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of stock-based compensation costs recognized in the Condensed Consolidated Statements of Income
The following table presents details of stock-based compensation costs recognized in the Consolidated Statements of Operations (in thousands):
Year Ended
December 28,
2024
December 30,
2023
December 31,
2022
Cost of revenues$1,678 $906 $1,152 
Research and development40,393 35,491 32,860 
Selling, general and administrative19,431 11,812 26,498 
61,503 48,208 60,510 
Income tax benefit(8,557)(6,230)(5,980)
Total$52,946 $41,978 $54,530 
Summary of assumptions used to estimate fair values for ESPP
The fair values estimated from the Black-Scholes option-pricing model for ESPP shares granted were calculated using the following assumptions:
Year Ended
Employee Stock Purchase PlanDecember 28,
2024
December 30,
2023
December 31,
2022
Expected volatility45 %40 %44 %
Risk-free interest rate %4.39 %5.47 %3.18 %
Expected term (in months)999
Dividend yield— — — 
Summary of stock-based compensation activity, options
A summary of stock-based compensation activity with respect to fiscal 2024 follows:
Stock OptionsShares
(000s)
Weighted-
Average
Exercise
Price
Weighted-Average
Remaining
Contractual Term
(In Years)
Aggregate
Intrinsic
Value
(000s)
Outstanding at December 30, 202394$39.03 2.12$8,790 
Exercised76$37.88 $6,063 
Outstanding at December 28, 202418$43.82 1.08$1,534 
Vested at December 28, 2024 and expected to vest18$43.82 1.08$1,534 
Exercisable at December 28, 202418$43.82 1.08$1,534 
Summary of stock-based compensation activity, RSAs and RSUs
RSAs and RSUsShares
(000s)
Weighted-
Average
Grant Date
Fair Value
Weighted-Average
Remaining
Vesting Term
(In Years)
Aggregate
Intrinsic
Value
(000s)
Outstanding at December 30, 2023824$138.95 
Granted605$125.19 
Vested or issued(385)$135.90 
Cancelled or forfeited(76)$129.69 
Outstanding at December 28, 2024968$132.26 1.22$123,685 
Outstanding at December 28, 2024 and expected to vest887$132.62 1.22$113,354 
Summary of stock-based compensation activity, PSUs and MSUs
PSUs and MSUsShares
(000s)
Weighted-
Average
Grant Date
Fair Value
Weighted-Average
Remaining
Vesting Term
(In Years)
Aggregate
Intrinsic
Value
(000s)
Outstanding at December 30, 2023245$164.62 
Granted116$138.22 
Vested or issued(55)$165.27 
Cancelled or forfeited(71)$143.51 
Outstanding at December 28, 2024235$165.73 1.23$30,069 
Outstanding at December 28, 2024 and expected to vest50$139.69 1.23$6,401 
Summary of weighted average fair value at the date of grant
The following summarizes the Company’s weighted average fair value at the date of grant:
Year Ended
December 28,
2024
December 30,
2023
December 31,
2022
Per grant of RSAs and RSUs$125.19 $137.11 $144.40 
Per grant of PSUs and MSUs$138.22 $188.45 $160.97 
Summary of stock-based payment and stock option values
The following summarizes the Company’s stock-based payment and stock option values (in thousands):
Year Ended
December 28,
2024
December 30,
2023
December 31,
2022
Intrinsic value of stock options exercised$6,063 $2,162 $— 
Intrinsic value of RSUs that vested$49,008 $61,371 $57,621 
Grant date fair value of RSUs that vested$52,371 $53,088 $41,610 
Intrinsic value of PSUs and MSUs that vested$7,202 $5,163 $— 
Grant date fair value of PSUs and MSUs that vested$9,067 $3,037 $— 
Summary of shares reserved of common stock for future issuance
As of December 28, 2024, the Company had reserved shares of common stock for future issuance as follows (in thousands):
2009 Plan1,522
2009 ESPP818
Total shares reserved2,340